Evaluating and improving bug-finding tools is currently difficult due to a shortage of ground truth corpora (i.e., software that has known bugs with triggering inputs). LAVA attempts to solve this ...

Will Kenton is an expert on the economy and investing laws and regulations. He previously held senior editorial roles at Investopedia and Kapitall Wire and holds a MA in Economics from The New School ...

University of California spinout Addition Therapeutics has uncloaked, revealing “breakthrough” PRINT technology it hopes will fuel a new wave of genetic medicine. Addition emerges from stealth with ...

Addition joins a growing list of launches this year, following in the footsteps of startups like Crystalys Therapeutics and Ollin Biosciences. Addition Therapy launched on Wednesday, armed with $100 ...

Addition Therapeutics has emerged from stealth with $100 million in hand to develop new types of gene therapies that might work against rare as well as chronic diseases. Spun out of research at the ...